Recent patterns in cutaneous melanoma descriptive epidemiology in the Slovak Republic

Neoplasma

Volumn 60, Issue 6, 2013, Pages 706-713

  Ondrusova, M ^a,b,c   Mrinakova, B ^d   Ondrus, D ^e   Polakova, K ^d   Durdik, S ^e  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b St Elisabeth University of Health and Social Work   (Slovakia)

^c St Elisabeth Cancer Institute ^*

^d St Elisabeth Cancer Institute   (Slovakia)

^e Faculty of Natural Sciences   (Slovakia)

Author keywords

Clinical stages; Cutaneous melanoma epidemiology; Incidence; Mortality; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHILD; CUTANEOUS MELANOMA; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; SCHOOL CHILD; SLOVAKIA; SOCIOECONOMICS; STANDARDIZED INCIDENCE RATIO; SUNBATHING; ULTRAVIOLET RADIATION; VERY ELDERLY; YOUNG ADULT; INCIDENCE; MELANOMA; MORTALITY; PROGNOSIS; RISK FACTOR; SKIN TUMOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS; SLOVAKIA; SURVIVAL RATE; YOUNG ADULT;

EID: 84887520764     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_090     Document Type: Article

References (27)

1. BARBE C, HIBON E, VITRY F, LE CLAINCHE A, GRANGE F Clinical and pathological characteristics of melanoma: a population-based study in a French regional population. J Eur Acad Dermatol Venereol 2012; 26: 159-164. http://dx.doi.org/10.1111/j.1468-3083.2011.04021.x
2. FERLAY J, SHIN HR, BRAY F, FORMAN D, MATHERS C et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon: IARC; 2010. Available from: http://globocan.iarc.fr/
3. BOYLE P, LEVIN B (eds.): World Cancer Report 2008, Lyon: IARC, 2008.
4. ONDRUSOVA M, PLESKO I, SAFAEI-DIBA C, OBSITNIKOVA A, STEFANAKOVA D et al. Comprehensive analysis of incidence and mortality of malignant tumours in the Slovak Republic [online]. Bratislava: NCR SR, NHIC, 2007. http://www.nor-sk.org/.
5. PARKIN DM, MESHER D, SASIENI P Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010. Br J Cancer 2011; 105: 566-569.
6. KISS S, SISKOVIC M, KULKA M Comparing of the standard of living in the Slovak Republic in 1989-2005 (in Slovak), Bratislava; 2006. Available from www.finance.gov. sk/ifp
7. ONDRUSOVA M, PLESKO I, SAFAEI-DIBA C, ONDRUS D, KOPECKA I Cancer incidence in the Slovak Republic 2003, 2nd ed., Bratislava: NCR SR, NHIC, 2007.
8. SAFAEI-DIBA C, PLESKO I, FRINDTOVA V, KOPECKA I, KRAKOVSKA B Cancer incidence in the Slovak Republic 2004. Bratislava: NCR SR, NHIC, 2008.
9. SAFAEI-DIBA C, PLESKO I, OBSITNIKOVA A, DIENEROVA M, KALMANCOKOVA A Cancer incidence in the Slovak Republic 2005. Bratislava: NCR SR, NHIC, 2009.
10. SAFAEI-DIBA CH, PLESKO I, HLAVA P (eds.). Cancer incidence in the Slovak Republic 2006. Bratislava: NCR SR, NHIC, 2010.
11. SAFAEI-DIBA CH, PLESKO I, HLAVA P (eds.). Cancer incidence in the Slovak Republic 2007. Bratislava: NCR SR, NHIC, 2012.
12. BRAY F, GUILLOUX A, SANKILA R, PARKIN DM Practical implications of imposing a new world standard population. Cancer Causes Control 2002; 13: 175-182. http://dx.doi.org/10.1023/A:1014344519276
13. NATIONAL CANCER INSTITUTE, Surveillance research: http://surveillance.cancer.gov/joinpoint/
14. KIM HJ, FAY MP, FEUER EJ, MIDTHUNE DN Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 16: 335-351. http://dx.doi.org/10.1002/(SICI)1097-0258(20000215)19:3<335::AIDSIM336>3.0.CO;2-Z
15. ZIVKOVIC MV, DEDIOL I, LJUBICIC I, SITUM M Sun behaviour patterns and perception of illness among melanoma patients. J Eur Acad Dermatol Venereol 2012; 26: 724-729. http://dx.doi.org/10.1111/j.1468-3083.2011.04154.x
16. FUGLEDE NB, BRINCK-CLAUSSE UO, DELTOUR I, BOESEN EH, DALTON SO et al. Incidence of cutaneous malignant melanoma in Denmark, 1978-2007. Br J Dermatol 2011; 162: 349-353.
17. MACKIE RM, HAUSCHILD A, EGGERMONT AM Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009; 20 suppl. 6:. vi1-vi7. http://dx.doi.org/10.1093/annonc/mdp252
18. ERDEI E, TORRES SM A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther 2010; 10: 1811-1823. http://dx.doi.org/10.1586/era.10.170
19. VRANOVA J, ARENBERGEROVA M, ARENBERGER P, STANEK J. VRANA A et al. Incidence of cutaneous malignant melanoma in the Czech Republic: the risk of sun exposure for adolescents. Neoplasma 2012; 59: 316-325. http://dx.doi.org/10.4149/neo_2012_041
20. VRANOVA J, ARENBERGEROVA M, ARENBERGER P, VRANA A, ZIVCAK J et al. Malignant melanoma in the Czech Republic: Incidence and mortality according to sex, age and disease stage. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Nov 2. doi: 10.5507/bp.2012.081. [Epub ahead of print] http://dx.doi.org/10.5507/bp.2012.081
21. FERLAY J, PARKIN DM, CURADO MP, BRAY F, EDWARDS B et al. Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9 [Internet]. Lyon: IARC; 2010. Available from: http://ci5.iarc.fr
22. ROBINSON JK, BAKER MK, HILHOUSE JJ. New approaches to melanoma prevention. Dermatol Clin. 2012l; 30: 405-412. http://dx.doi.org/10.1016/j.det.2012.04.006
23. RIKER AI, ZEA N, TRINH T. The epidemiology, prevention and detection of melanoma. Ochsner J 2010; 10: 1056-1065.
24. WHO, mortality database, http://www.who.int/whosis/mort/download/en/index.html(accessed on24/11/2011)
25. POLLACK LA, LI J, BERKOWITZ Z, WEIR HK, WU XC et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol 2011; 65(5 Suppl 1): S78-86.
26. TRYGGVADÓTTIR L, GISLUM M, HAKULINEN T, KLINT A, ENGHOLM G et al. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49: 665-672. http://dx.doi.org/10.3109/02841861003702528
27. ONDRUS D, ONDRUSOVA M Recent patterns in testicular cancer incidence, mortality and survival in the Slovak Republic with reference to international comparisons. Cancer Invest 2012; 30: 545-551. http://dx.doi.org/10.3109/07357907.2012.700984